Crossmark

Combination therapy for HCC: from CRISPR screening to the design of clinical therapies

Published Online: 2021-10-04

Authors

Wang, Yunguang

Kui, Ling

Wang, Guangchuan https://orcid.org/0000-0001-5315-1599
License Information

Text and Data Mining valid from 2021-10-04

Version of Record valid from 2021-10-04
More Information

Article History

Received: 8 August 2021

Revised: 14 September 2021

Accepted: 22 September 2021

First Online: 4 October 2021

Competing interests

: The authors declare no competing interests.

Document is current